A positive trend in breast cancer risk was observed with increasing cumulative use of insulin, the estimate being 1.46 (95% CI 1.19–1.81) for the amount of DDDs being 1200 or more when compared with no use at any time (Fig. 2). The gene discussed is INS; the disease is breast cancer.